Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News China Pharma Holdings Inc. CPHI

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.


Recent & Breaking News (NYSEAM:CPHI)

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

PR Newswire 5 days ago

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

PR Newswire July 18, 2022

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

PR Newswire June 22, 2022

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

PR Newswire March 31, 2022

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

PR Newswire November 12, 2021

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

PR Newswire August 13, 2021

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

PR Newswire August 5, 2021

China Pharma to Launch Highly Purified NMN+PQQ Product

PR Newswire June 9, 2021

China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

PR Newswire May 14, 2021

China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port

PR Newswire April 19, 2021

China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results

PR Newswire March 26, 2021

China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results

PR Newswire November 13, 2020

China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks

PR Newswire September 21, 2020

China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results

PR Newswire August 14, 2020

CPHI to Hold Second Quarter 2020 Earnings Conference Call On Friday August 14, 2020 at 8:30 a.m. ET

PR Newswire August 11, 2020

China Pharma Holdings, Inc. Reports First Quarter 2020 Financial Results

PR Newswire May 15, 2020

China Pharmaceutical Holdings Co., Ltd. Added Mask Production Lines

PR Newswire April 15, 2020

Updates - China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results

PR Newswire April 14, 2020

China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results

PR Newswire March 31, 2020

CPHI to Hold Fiscal Year 2019 Earnings Conference Call On Tuesday March 31, 2020 at 8:30 a.m. ET

PR Newswire March 13, 2020